A Head and Shoulders (H&S) pattern is a reversal pattern that forms
after an uptrend. A textbook H&S pattern starts to form when a stock
rallies to a point and then pulls back to a particular level (left
shoulder). Next, the stock will rally again, but this time to a higher
peak (head) than the previous one. After forming the head, the stock
will pull back to the same support that the first shoulder did. Finally,
the stock rallies a 3rd time, but not as high as the head (right
shoulder). The level that has been created by all 3 of the pullbacks is
simply a support level referred to as the "neckline". The formation of
an H&S pattern warns of a potential reversal of the uptrend into a
possible downtrend.
Hologic Inc. develops, manufactures, and supplies diagnostic, medical imaging systems, and surgical products for the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment offers breast imaging products, such as Selenia full field digital mammography system, breast tomosynthesis, healthcome mammography products, screen-film mammography systems, SecurView workstation, CAD systems, stereotactic breast biopsy systems, breast biopsy products, breast brachytherapy products, MammoPad breast cushions, and photoconductor coatings, as well as Sentinelle medical MRI breast coils and workstations. The Diagnostics segment provides ThinPrep system, a solution for cervical cancer screening; rapid fetal fibronectin test for pre-term birth risk assessment. The GYN Surgical segment offers NovaSure system, a minimally-invasive procedure that allows physicians to treat women suffering from excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids. The Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites.
To review the H&S pattern that has formed on Hologic's stock, please take a look at the 1-year chart of HOLX (Hologic, Inc.) below with my added notations:
Hologic Inc. develops, manufactures, and supplies diagnostic, medical imaging systems, and surgical products for the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment offers breast imaging products, such as Selenia full field digital mammography system, breast tomosynthesis, healthcome mammography products, screen-film mammography systems, SecurView workstation, CAD systems, stereotactic breast biopsy systems, breast biopsy products, breast brachytherapy products, MammoPad breast cushions, and photoconductor coatings, as well as Sentinelle medical MRI breast coils and workstations. The Diagnostics segment provides ThinPrep system, a solution for cervical cancer screening; rapid fetal fibronectin test for pre-term birth risk assessment. The GYN Surgical segment offers NovaSure system, a minimally-invasive procedure that allows physicians to treat women suffering from excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids. The Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites.
To review the H&S pattern that has formed on Hologic's stock, please take a look at the 1-year chart of HOLX (Hologic, Inc.) below with my added notations:
HOLX has been trending higher since June. Over the last (2) months
though, the stock has created a key price level at $20 (red), which
would also be the "neckline" support for the H&S pattern. Above the
neckline you will notice the H&S pattern itself (blue). Confirmation
of the H&S would occur if HOLX broke its $20 "neckline" support. If
that happens, the stock should be moving lower from there.
One needs to look no further than this past April to see what could result if HOLX breaks $20. The stock created an H&S pattern then too with the same $20 support.
One needs to look no further than this past April to see what could result if HOLX breaks $20. The stock created an H&S pattern then too with the same $20 support.
No comments:
Post a Comment